Mr. Buckler has been an executive in the cell therapy sector since 2000 beginning with Malachite Management in the Stem Cell Technologies group of companies. He served just over two years as Director of Business Development for Progenitor Cell Therapy prior to its acquisition by NeoStem and then Hitachi Chemical Advanced Therapeutics Solutions. Most recently he was the Managing Director of Cell Therapy Group, a consulting firm he formed in 2008.  

Mr. Buckler holds a Bachelor's Degree in Education and a Law Degree. After law school, he did a one year judicial clerkship with the B.C. Supreme Court and was a practicing attorney for three years at Edwards, Kenny & Bray. Mr. Buckler served six years as the Executive Director of the International Society for Cellular Therapy, was the inaugural chair of the Alliance for Regenerative Medicine's Communications and Education Committee, co-founded Cell Therapy News, founded Cell Therapy Blog, founded and continues to manage the LinkedIn Cell Therapy Industry Group, serves on the editorial advisory boards for the journals Regenerative Medicine and Cell and Gene Therapy Insights, and the advisory boards for Phacilitate: Exchange and RoosterBio. He is a frequent commentator, analyst, author and speaker in cell therapy.